Information

Dear user, the application need JavaScript support. Please enable JavaScript in your browser.

English (EN)·Polski (PL)·Ukraiński (UK)
Go to the home page of the library Uniwersytet Ekonomiczny we Wrocławiu Link opens in a new window Library logo Prolib Integro - home pageUniwersytet Ekonomiczny we Wrocławiu

You search for a phrase ""Salvage Therapy"" according to the criterion: Subject Terms

  Filters
Align
Showing 1-20 from 8710 results
Title:
Salvage treatment of acute respiratory failure after autogenous tissue flap transplantation for chronic empyema with chest wall sinus: a case report and literature review.
Authors:
Wang L; Department of Cardiothoracic Surgery, Tongde Hospital of Zhejiang Province, 234 Gucui Rd, Hangzhou, China.
Chen F; Department of Cardiothoracic Surgery, Tongde Hospital of Zhejiang Province, 234 Gucui Rd, Hangzhou, China. .
He Z; Department of Cardiothoracic Surgery, Tongde Hospital of Zhejiang Province, 234 Gucui Rd, Hangzhou, China.
He X; Department of Cardiothoracic Surgery, Tongde Hospital of Zhejiang Province, 234 Gucui Rd, Hangzhou, China.
Zhang C; Department of Traumatology and Orthopedic Surgery, Tongde Hospital of Zhejiang Province, 310012, Hangzhou, Zhejiang, China.
Show more
Source:
Journal of cardiothoracic surgery [J Cardiothorac Surg] 2024 Jan 30; Vol. 19 (1), pp. 32. Date of Electronic Publication: 2024 Jan 30.
Publication Type:
Review; Case Reports; Journal Article
MeSH Terms:
Respiratory Distress Syndrome*/etiology
Respiratory Distress Syndrome*/therapy
Respiratory Insufficiency*/etiology
Respiratory Insufficiency*/therapy
Salvage Therapy*
Humans ; Male ; Middle Aged ; Bronchial Fistula/surgery ; Empyema, Pleural/complications ; Empyema, Pleural/surgery ; Pneumonectomy/adverse effects ; Thoracic Wall
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
A review of treatment options employed in relapsed/refractory AML.
Authors:
Mohamed Jiffry MZ; Department of Internal Medicine, Danbury Hospital, Danbury, CT, USA.
Kloss R; Department of Hematology & Oncology, Danbury Hospital, Danbury, CT, USA.
Ahmed-Khan M; School of Medicine, American University of the Caribbean, Cupecoy, Sint Maarten.
Carmona-Pires F; School of Medicine, American University of the Caribbean, Cupecoy, Sint Maarten.
Okam N; School of Medicine, American University of the Caribbean, Cupecoy, Sint Maarten.
Weeraddana P; School of Medicine, American University of the Caribbean, Cupecoy, Sint Maarten.
Dharmaratna D; School of Medicine, American University of the Caribbean, Cupecoy, Sint Maarten.
Dandwani M; Department of Internal Medicine, Danbury Hospital, Danbury, CT, USA.
Moin K; School of Medicine, American University of the Caribbean, Cupecoy, Sint Maarten.
Show more
Source:
Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2196482.
Publication Type:
Review; Journal Article
MeSH Terms:
Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/therapy
Humans ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Hematopoietic Stem Cell Transplantation/methods ; Recurrence ; Salvage Therapy
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Biomarkers for Salvage Therapy in Testicular Germ Cell Tumors.
Authors:
Urbini M; Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, Italy.
Bleve S; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, Italy.
Schepisi G; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, Italy.
Menna C; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, Italy.
Gurioli G; Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, Italy.
Gianni C; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, Italy.
De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, Italy.
Show more
Source:
International journal of molecular sciences [Int J Mol Sci] 2023 Nov 28; Vol. 24 (23). Date of Electronic Publication: 2023 Nov 28.
Publication Type:
Journal Article; Review
MeSH Terms:
Hematopoietic Stem Cell Transplantation*
Testicular Neoplasms*/therapy
Testicular Neoplasms*/drug therapy
Neoplasms, Germ Cell and Embryonal*/diagnosis
Neoplasms, Germ Cell and Embryonal*/genetics
Neoplasms, Germ Cell and Embryonal*/therapy
Male ; Humans ; Salvage Therapy ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Neoplasm Recurrence, Local/drug therapy ; Transplantation, Autologous ; Cisplatin/therapeutic use ; Biomarkers
SCR Disease Name:
Testicular Germ Cell Tumor
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Venetoclax-based salvage therapy in patients with relapsed/refractory acute myeloid leukemia previously treated with FLT3 or IDH1/2 inhibitors.
Authors:
Bewersdorf JP; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Shallis RM; Yale University and Yale Cancer Center, New Haven, CT, USA.
Derkach A; Department of Biostatistics and Epidemiology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Goldberg AD; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Stein A; City of Hope National Medical Center, Duarte, CA, USA.
Stein EM; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Marcucci G; City of Hope National Medical Center, Duarte, CA, USA.
Zeidan AM; Yale University and Yale Cancer Center, New Haven, CT, USA.
Shimony S; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA, USA.
DeAngelo DJ; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA, USA.
Stone RM; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA, USA.
Aldoss I; City of Hope National Medical Center, Duarte, CA, USA.
Ball BJ; City of Hope National Medical Center, Duarte, CA, USA.
Stahl M; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA, USA.
Show more
Source:
Leukemia & lymphoma [Leuk Lymphoma] 2023 Jan; Vol. 64 (1), pp. 188-196. Date of Electronic Publication: 2022 Oct 26.
Publication Type:
Multicenter Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Salvage Therapy*
Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/genetics
Humans ; Retrospective Studies ; Bridged Bicyclo Compounds, Heterocyclic ; fms-Like Tyrosine Kinase 3/genetics ; Isocitrate Dehydrogenase/genetics
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Salvage cryotherapy for prostate cancer.
Authors:
E Brito DV; Urology Department Portuguese Institute of Oncology Coimbra. .
Pereira JA; Urology Department Portuguese Institute of Oncology Coimbra. .
Ferreira AM; Urology Department Portuguese Institute of Oncology Coimbra. .
Lourenço M; Urology Department Portuguese Institute of Oncology Coimbra. .
Godinho R; Urology Department Portuguese Institute of Oncology Coimbra. .
Pereira B; Urology Department Portuguese Institute of Oncology Coimbra. .
Peralta P; Urology Department Portuguese Institute of Oncology Coimbra. .
Conceiçao P; Urology Department Portuguese Institute of Oncology Coimbra. .
Reis M; Urology Department Portuguese Institute of Oncology Coimbra. .
Rabaça C; Urology Department Portuguese Institute of Oncology Coimbra. .
Show more
Source:
Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica [Arch Ital Urol Androl] 2024 Jan 08; Vol. 95 (4), pp. 11897. Date of Electronic Publication: 2024 Jan 08.
Publication Type:
Journal Article
MeSH Terms:
Cryotherapy*
Prostatic Neoplasms*/therapy
Male ; Humans ; Middle Aged ; Aged ; Prostate ; Pelvis ; Salvage Therapy
Academic Journal
Full Text  Link opens in a new windowDetails
Title:
Long-term follow up of systemic rituximab therapy as first-line and salvage therapy for idiopathic orbital inflammation and review of the literature.
Authors:
Abou-Hanna JJ; Department of Ophthalmology and Visual Science, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA.
Tiu Teo HM; Department of Ophthalmology and Visual Science, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA.
Thangavel R; Department of Ophthalmology and Visual Science, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA.
Elner VM; Department of Ophthalmology and Visual Science, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA.
Demirci H; Department of Ophthalmology and Visual Science, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA.
Show more
Source:
Orbit (Amsterdam, Netherlands) [Orbit] 2022 Jun; Vol. 41 (3), pp. 297-304. Date of Electronic Publication: 2021 Jan 21.
Publication Type:
Journal Article; Review
MeSH Terms:
Orbital Pseudotumor*/diagnosis
Salvage Therapy*
Aged ; Follow-Up Studies ; Humans ; Inflammation/drug therapy ; Middle Aged ; Rituximab/therapeutic use
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Outcomes of Salvage Therapy for Oropharyngeal Cancer Recurrence Following Upfront Radiation Therapy and Prognostic Factors.
Authors:
Choi N; Department of Otorhinolaryngology, Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kim HJ; Department of Otorhinolaryngology, Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Yi H; Department of Otorhinolaryngology, Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kim H; Department of Otorhinolaryngology, Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kim TH; Department of Otorhinolaryngology, Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Jeong HS; Department of Otorhinolaryngology, Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Son YI; Department of Otorhinolaryngology, Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Baek CH; Department of Otorhinolaryngology, Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Oh D; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Ahn YC; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Chung MK; Department of Otorhinolaryngology, Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Show more
Source:
Cancer research and treatment [Cancer Res Treat] 2023 Oct; Vol. 55 (4), pp. 1123-1133. Date of Electronic Publication: 2023 May 08.
Publication Type:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/radiotherapy
Carcinoma, Squamous Cell*/surgery
Oropharyngeal Neoplasms*/surgery
Oropharyngeal Neoplasms*/pathology
Head and Neck Neoplasms*
Humans ; Salvage Therapy/methods ; Prognosis ; Margins of Excision ; Neoplasm Recurrence, Local/pathology ; Squamous Cell Carcinoma of Head and Neck ; Chemoradiotherapy ; Retrospective Studies ; Treatment Outcome
Academic Journal
Full Text  Link opens in a new windowDetails
Title:
Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan.
Authors:
Tsuchihashi, Kenji (AUTHOR)
Ito, Mamoru (AUTHOR)
Arita, Shuji (AUTHOR)
Kusaba, Hitoshi (AUTHOR)
Kusano, Wataru (AUTHOR)
Matsumura, Takashi (AUTHOR)
Kitazono, Takafumi (AUTHOR)
Ueno, Shohei (AUTHOR)
Taguchi, Ryosuke (AUTHOR)
Yoshihiro, Tomoyasu (AUTHOR)
Doi, Yasuhiro (AUTHOR)
Arimizu, Kohei (AUTHOR)
Ohmura, Hirofumi (AUTHOR)
Kajitani, Tatsuhiro (AUTHOR)
Nio, Kenta (AUTHOR)
Nakano, Michitaka (AUTHOR)
Oshima, Kotoe (AUTHOR)
Tamura, Shingo (AUTHOR)
Shirakawa, Tsuyoshi (AUTHOR)
Shimokawa, Hozumi (AUTHOR)
Show more
Source:
BMC Cancer. 10/30/2023, Vol. 23 Issue 1, p1-9. 9p.
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha-fetoprotein levels.
Authors:
Hsu PY; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Cheng TS; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chuang SC; Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chang WT; Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Liang PC; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Hsu CT; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Wei YJ; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Jang TY; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Yeh ML; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang CI; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Lin YH; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Wang CW; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Hsieh MY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Hou NJ; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Hsieh MH; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.
Tsai YS; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Ko YM; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Lin CC; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chen KY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Dai CY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Lin ZY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chen SC; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang JF; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chuang WL; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang CF; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.
Yu ML; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.; National Pingtung University of Science and Technology, Pingtung, Taiwan.
Show more
Source:
Cancer medicine [Cancer Med] 2022 Jan; Vol. 11 (1), pp. 104-116. Date of Electronic Publication: 2021 Nov 16.
Publication Type:
Journal Article
MeSH Terms:
Salvage Therapy*
Antineoplastic Agents/*therapeutic use
Carcinoma, Hepatocellular/*drug therapy
Liver Neoplasms/*drug therapy
Phenylurea Compounds/*therapeutic use
Pyridines/*therapeutic use
Sorafenib/*therapeutic use
alpha-Fetoproteins/*metabolism
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/adverse effects ; Carcinoma, Hepatocellular/blood ; Disease Progression ; Female ; Humans ; Liver Neoplasms/blood ; Male ; Middle Aged ; Phenylurea Compounds/adverse effects ; Pyridines/adverse effects ; Risk Factors ; Survival Analysis ; Taiwan
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
A prospective phase II study of raltitrexed combined with S-1 as salvage treatment for patients with refractory metastatic colorectal cancer.
Authors:
Huang M; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Yang Y; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Zhu X; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Chen Z; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Zhang W; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Wang C; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Zhang X; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Qiu L; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Zhang Z; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Zhao X; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Li W; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Wang Y; Shanxi Cancer Hospital, Taiyuan, China.
Guo W; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Show more
Source:
Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2021 Dec; Vol. 17 (6), pp. 513-521. Date of Electronic Publication: 2021 Feb 10.
Publication Type:
Clinical Trial, Phase II; Journal Article
MeSH Terms:
Colorectal Neoplasms*/drug therapy
Salvage Therapy*
Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Camptothecin/therapeutic use ; Fluorouracil/therapeutic use ; Humans ; Leucovorin ; Prospective Studies ; Quinazolines ; Thiophenes ; Treatment Outcome
Academic Journal
Full Text  Link opens in a new windowDetails
Title:
The future of salvage lymph node dissection in the prostate-specific membrane antigen era.
Authors:
Plata Bello A; University Hospital of Canary Islands, La Laguna, Tenerife, Canary Islands, Spain.
Touijer KA; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Show more
Source:
BJU international [BJU Int] 2021 Nov; Vol. 128 (5), pp. 652-653.
Publication Type:
Editorial; Comment
MeSH Terms:
Prostate*
Salvage Therapy*
Humans ; Lymph Node Excision ; Male
Editorial & Opinion
Full Text  Link opens in a new window Full TextDetails
Title:
Results of salvage therapy with mini-hyper-CVD and inotuzumab ozogamicin with or without blinatumomab in pre-B acute lymphoblastic leukemia.
Authors:
Kantarjian, Hagop (AUTHOR)
Haddad, Fadi G. (AUTHOR)
Jain, Nitin (AUTHOR)
Sasaki, Koji (AUTHOR)
Short, Nicholas J. (AUTHOR)
Loghavi, Sanam (AUTHOR)
Kanagal-Shamanna, Rashmi (AUTHOR)
Jorgensen, Jeffrey (AUTHOR)
Khouri, Issa (AUTHOR)
Kebriaei, Partow (AUTHOR)
Alvarado, Yesid (AUTHOR)
Kadia, Tapan (AUTHOR)
Paul, Shilpa (AUTHOR)
Garcia-Manero, Guillermo (AUTHOR)
Dabaja, Bouthaina (AUTHOR)
Yilmaz, Musa (AUTHOR)
Jacob, Jovitta (AUTHOR)
Garris, Rebecca (AUTHOR)
O'Brien, Susan (AUTHOR)
Ravandi, Farhad (AUTHOR)
Show more
Source:
Journal of Hematology & Oncology. 5/2/2023, Vol. 16 Issue 1, p1-12. 12p.
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Anti-PD-1 antibodies as a salvage therapy for patients with diffuse large B cell lymphoma who progressed/relapsed after CART19/20 therapy.
Authors:
Wang C; Department of Bio-Therapeutic, the First Medical Centre in Chinese PLA General Hospital, Beijing, China.
Shi F; Department of Bio-Therapeutic, the First Medical Centre in Chinese PLA General Hospital, Beijing, China.
Liu Y; Department of Bio-Therapeutic, the First Medical Centre in Chinese PLA General Hospital, Beijing, China.
Zhang Y; Department of Bio-Therapeutic, the First Medical Centre in Chinese PLA General Hospital, Beijing, China.
Dong L; Department of Bio-Therapeutic, the First Medical Centre in Chinese PLA General Hospital, Beijing, China.
Li X; Department of Bio-Therapeutic, the First Medical Centre in Chinese PLA General Hospital, Beijing, China.
Tong C; Department of Bio-Therapeutic, the First Medical Centre in Chinese PLA General Hospital, Beijing, China.
Wang Y; Department of Bio-Therapeutic, the First Medical Centre in Chinese PLA General Hospital, Beijing, China.
Su L; Department of Hematology, Shanxi Cancer Hospital, Taiyuan, Shanxi, China.
Nie J; Department of Bio-Therapeutic, the First Medical Centre in Chinese PLA General Hospital, Beijing, China. .
Han W; Department of Bio-Therapeutic, the First Medical Centre in Chinese PLA General Hospital, Beijing, China. .
Show more
Source:
Journal of hematology & oncology [J Hematol Oncol] 2021 Jul 05; Vol. 14 (1), pp. 106. Date of Electronic Publication: 2021 Jul 05.
Publication Type:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunotherapy, Adoptive*/methods
Salvage Therapy*/methods
Immune Checkpoint Inhibitors/*therapeutic use
Lymphoma, Large B-Cell, Diffuse/*therapy
Neoplasm Recurrence, Local/*therapy
Adult ; Antigens, CD19/immunology ; Antigens, CD20/immunology ; Female ; Humans ; Lymphoma, Large B-Cell, Diffuse/immunology ; Male ; Middle Aged ; Neoplasm Recurrence, Local/immunology ; Receptors, Antigen, T-Cell/therapeutic use ; Retrospective Studies
Report
Full Text  Link opens in a new window Full TextDetails
Title:
Effectiveness and Safety of Clofarabine Monotherapy or Combination Treatment in Relapsed/Refractory Childhood Acute Lymphoblastic Leukemia: A Pragmatic, Non-interventional Study in Korea.
Authors:
Choi JY; Department of Pediatrics, Seoul National University Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Hong CR; Department of Pediatrics, Seoul National University Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Hong KT; Department of Pediatrics, Seoul National University Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Kang HJ; Department of Pediatrics, Seoul National University Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Kim S; Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Lee JW; Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Jang PS; Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Chung NG; Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Cho B; Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Kim H; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Korea.
Koh KN; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Korea.
Im HJ; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Korea.
Seo JJ; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Korea.
Hahn SM; Division of Pediatric Hematology and Oncology, Department of Pediatrics, Yonsei University Health System, Yonsei University College of Medicine, Seoul, Korea.
Han JW; Division of Pediatric Hematology and Oncology, Department of Pediatrics, Yonsei University Health System, Yonsei University College of Medicine, Seoul, Korea.
Lyu CJ; Division of Pediatric Hematology and Oncology, Department of Pediatrics, Yonsei University Health System, Yonsei University College of Medicine, Seoul, Korea.
Yang EJ; Department of Pediatrics, Pusan National University Children's Hospital, Pusan National University School of Medicine, Yangsan, Korea.
Lim YT; Department of Pediatrics, Pusan National University Children's Hospital, Pusan National University School of Medicine, Yangsan, Korea.
Yoo KH; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Koo HH; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kook H; Department of Pediatrics, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea.
Jeon IS; Department of Pediatrics, Gachon University, Gil Medical Center, Incheon, Korea.
Cho H; Sanofi Aventis, Seoul, Korea.
Shin HY; Department of Pediatrics, Seoul National University Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Show more
Source:
Cancer research and treatment [Cancer Res Treat] 2021 Oct; Vol. 53 (4), pp. 1184-1194. Date of Electronic Publication: 2021 Jan 04.
Publication Type:
Journal Article; Multicenter Study; Observational Study
MeSH Terms:
Drug Resistance, Neoplasm*
Salvage Therapy*
Clofarabine/*therapeutic use
Hematopoietic Stem Cell Transplantation/*mortality
Neoplasm Recurrence, Local/*therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
Adolescent ; Adult ; Antimetabolites, Antineoplastic/therapeutic use ; Child ; Child, Preschool ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Humans ; Male ; Neoplasm Recurrence, Local/pathology ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/epidemiology ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology ; Prognosis ; Prospective Studies ; Republic of Korea/epidemiology ; Survival Rate ; Young Adult
Academic Journal
Full Text  Link opens in a new windowDetails
Title:
Tumor growth rate during re-challenge chemotherapy with previously used agents as salvage treatment for metastatic colorectal cancer: A retrospective study.
Authors:
Ishikawa M; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
Takashima A; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Nagata Y; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
Sawada R; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
Aoki M; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Imazeki H; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Hirano H; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Shoji H; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Honma Y; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Iwasa S; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Okita N; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Kato K; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Saruta M; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
Boku N; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Show more
Source:
PloS one [PLoS One] 2021 Sep 24; Vol. 16 (9), pp. e0257551. Date of Electronic Publication: 2021 Sep 24 (Print Publication: 2021).
Publication Type:
Journal Article
MeSH Terms:
Colonic Neoplasms*
Salvage Therapy*
Adult ; Aged ; Disease-Free Survival ; Humans ; Male ; Middle Aged ; Progression-Free Survival ; Retrospective Studies
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Favorable prognosis of breast cancer brain metastases patients with limited intracranial and extracranial metastatic lesions.
Authors:
Shi W; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China.
Li Y; Affiliated Hospital of Jining Medical University, Jining, 272029, Shandong, China.
Sun H; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China.
Zhang L; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China.
Meng J; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China.
Wang X; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China.
Chen X; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China.
Zhang X; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China.
Mei X; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China.
Ma J; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China.
Mo M; Department of Cancer Prevention and Clinical Statistics Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Zhou C; Department of Cancer Prevention and Clinical Statistics Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Liang F; Department of Biostatistics, Zhongshan Hospital, Fudan University, Shanghai, China.
Shao Z; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Zhang Z; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China.
Guo X; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China.
Yu X; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China. .; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. .; Shanghai Clinical Research Center for Radiation Oncology, Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China. .
Yang Z; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China. .; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. .; Shanghai Clinical Research Center for Radiation Oncology, Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, China. .
Show more
Source:
Radiation oncology (London, England) [Radiat Oncol] 2023 Jul 01; Vol. 18 (1), pp. 107. Date of Electronic Publication: 2023 Jul 01.
Publication Type:
Journal Article
MeSH Terms:
Breast Neoplasms*/therapy
Brain Neoplasms*/therapy
Humans ; Female ; Prognosis ; Breast ; Salvage Therapy
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Showing 1-20 from 8710 results

We use cookies to help identify your computer so we can tailor your user experience, track shopping basket contents and remember where you are in the order process.